RE: Dosing tool14 Aug 2025 09:21
KingHomer,
As they stated in the July RNS,
"Following several iterations of software deployment, evaluation and debugging, the Company has successfully implemented its dosing software onto DoseMe's latest platform. This now allows the tool to be made available to clinicians and health care providers on a research-only basis allowing for important human factor evaluation and additional validation data to be generated."
Can you confirm,
1. This was a delay in getting the software implemented onto theDoseMeRX platform, from the original expectation?
2. That if they were only in July started to roll it out to some Physicians on a research only basis for further validation. that this validation period is likely to be a period of 12-18 months, or perhaps more?
Only after investing in medical stocks (Pharma, Biotech, Device manufacturers and CROs) for decades, I can confirm that times for validation are long, that timescales are rarely met and patience is needed in truckloads to see a product/platform actually get to commercialisation.